Head-to-head · Cost-Efficiency Index
myRocky vs Thryve
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
myRocky
Cost-first shoppers who want the real FDA-approved branded pens (not a compounded copy), for shoppers willing to pay branded-drug prices.
Visit myRockyThryve
Not currently recommendable — include only for completeness while the underlying site remains this undocumented.
Visit ThryveThe verdict
myRocky takes it, leading the Cost-Efficiency Index 38 to 22. myRocky is a US-facing telehealth platform selling only branded GLP-1s Ozempic ($1,409 listed), Wegovy ($1,869 listed), and Mounjaro ($1,509 listed) dispensed by LegitScript-approved MyRocky Pharmacy (license #308582). Thryve still earns a C — Not currently recommendable — include only for completeness while the underlying site remains this undocumented.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs myRocky.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | myRocky | Thryve |
|---|---|---|
| Cost-Efficiency Index | 38/100 | 22/100 |
| Semaglutide / mo | $1,409/mo (brand Ozempic, plus a separate fee) | $99/mo (drug not specified — site never names semaglutide or tirzepatide) |
| Tirzepatide / mo | $1,509/mo (brand Mounjaro, plus a separate fee) | $99/mo (drug not specified — site never names semaglutide or tirzepatide) |
| Semaglutide / yr (modeled) | $16,908 | $1,188 |
| Tirzepatide / yr (modeled) | $18,108 | $1,188 |
| Coverage | Coverage not published | Not disclosed |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #535 | #539 |
myRocky
38/100Where the value is
- Sells only genuine FDA-approved branded medications (Ozempic, Wegovy, Mounjaro) rather than compounded copies — a real differentiator from most of the other sites in this batch
- LegitScript-approved pharmacy, publishing the number #308582 beside that claim (we could not resolve it as a LegitScript seal ID in August 2026; it may be a pharmacy license number, which that registry would not serve)
- Explicit 42-state coverage list published on a dedicated service-coverage page, with 8 more states named as 'coming soon' — more specific than most peers' vague language
The tradeoffs
- Pricing is split across a $99 consult, a separate $99/month program fee, and the drug cost itself — a shopper reading only '$99/month' would badly underestimate the real all-in cost
- None of the three drug-specific pages (Ozempic $1,409, Wegovy $1,869, Mounjaro $1,509) discloses whether that figure is a one-month or multi-month supply
Thryve
22/100Where the value is
- A low headline price is advertised, if a reader wants to investigate directly
The tradeoffs
- Never names which drug is being sold — no mention of semaglutide, tirzepatide, or any other active ingredient anywhere on the site
- No dose, no state-coverage list, no named clinician, and no named pharmacy found anywhere
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.